Reversible hypopigmentation with pazopanib
Tablet Pazopanib known to cause Hypo pigmentation and Hyperpigmentation as per various literature reports. We report here a case of reversible hypopigmentation with Pazopanib in a patient treated for spindle cell sarcoma. Patient did not have any clinical symptoms except for cosmetic significance.
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2018-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Assuntos: | |
| Acceso en liña: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2018;volume=39;issue=4;spage=519;epage=520;aulast=Srinivasa |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|